The Dr Jack Watters debate: Tackling antimicrobial resistance in an ageing society Wednesday, 16 th November 2016 This event is kindly supported by Pfizer #futureofAMR
Jan 10, 2017
The Dr Jack Watters debate: Tackling antimicrobial resistance in an
ageing society
Wednesday, 16th November 2016
This event is kindly supported by Pfizer
#futureofAMR
Welcome
Baroness Sally GreengrossChief Executive
ILC-UK
This event is kindly supported by Pfizer
#futureofAMR
Welcome
Paula DeColaSenior Director, Global Patient Affairs
Pfizer
This event is kindly supported by Pfizer
#futureofAMR
Professor David SalisburyAssociate Fellow
Centre for Global Health Security Chatham House
This event is kindly supported by Pfizer
#futureofAMR
Antimicrobial resistance in an ageing population
Prof. David Salisbury CB FRCP FRCPCH FFPH FMedSciAssociate Fellow, Centre on Global Health Security,
Royal Institute for International Affairs, Chatham House, London.
Debate: The role of vaccines and antimicrobial resistance in an ageing population.
There is no debate!
Vaccines that we already use that are relevant to an ageing society.
Rotavirus vaccine for young children.Pneumococcal conjugate vaccine for young children.Meningococcal vaccines (C, B, Y, W)Haemophilus influenza b for young children.Influenza vaccine for children and risk groups.Varicella zoster vaccine
Haemophilus influenzae type b – Laboratory ReportsEngland 1990 - 2012
Very successful control of Invasive Hib Disease
Neisseria meningitidis type C (MenC). E&W;
1998 – 2009.
0
100
200
300400
500
600
700
800
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009
Year
Num
ber o
f Men
C c
ases
Under 20 years old
Over 20 years old
Introduction of the Meningococcal C vaccine
Source HPA
Impact of PCV 7 and 13
Cases in children >5 years
0
50
100
150
200
250
300
350
400
450
500
1997/8 1998/9 1999/0 2000/1 2001/2 2002/3 2003/4 2004/5 2005/6 2006/7 2007/8 2008/9
Epidemiological year
Num
ber o
f Cas
es
4, 6B, 9V, 14, 18C, 19F and 23F serotypes contained in Prevenar and Prevenar 13Prevenar introduced into the routine childhood immunisation schedule in 2006
Source HPA
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/503291/Norovirus_update_2016_week_06.pdf
Vaccines that we may use that are relevant to an ageing society.
RSV vaccine for children and older ages.Staph. aureusC. difficileE. coliNorovirus (children, risk groups, older individuals)PseudomonasKlebsiella
Alzheimer’sDiabetesCancer vaccines
Debate: The role of vaccines in antimicrobial resistance in an ageing population
Why have vaccines not received a higher profile?
Matthew EdwardsHead of Mortality and Longevity
Willis Towers Watson
This event is kindly supported by Pfizer
#futureofAMR
Michelle BresnahanCo-Founder
A Life for a Cure
This event is kindly supported by Pfizer
#futureofAMR
Panel DiscussionMichelle Bresnahan
Co-FounderA Life for a Cure
This event is kindly supported by Pfizer
#futureofAMR
Prof David SalisburyAssociate Fellow, Centre for Global
Health Security Chatham House
Dr Gina RadfordDeputy Chief Medical Officer
Close
Baroness Sally GreengrossChief Executive
ILC-UK
This event is kindly supported by Pfizer
#futureofAMR